A bispecific antibody targeting IGF-1R and EGFR was able to inhibit tumour growth and prevent lung metastases in a mouse osteosarcoma model [256], suggesting that it may have potential as a therapy for metastatic osteosarcoma, though this has yet to be tested clinically. The gene discussed is IGF1R; the disease is neoplasm.